Esophageal adenocarcinoma: treatment modalities in the era of targeted therapy.

Mukherjee K, Chakravarthy AB, Goff LW, El-Rifai W
Dig Dis Sci. 2010 55 (12): 3304-14

PMID: 20300841 · PMCID: PMC2890301 · DOI:10.1007/s10620-010-1187-4

MeSH Terms (15)

Adenocarcinoma Angiogenesis Inhibitors Antineoplastic Agents Aurora Kinases Barrett Esophagus Clinical Trials as Topic Combined Modality Therapy Disease Progression ErbB Receptors Esophageal Neoplasms Esophagectomy Humans Molecular Targeted Therapy Protein Serine-Threonine Kinases Treatment Outcome

Connections (2)

This publication is referenced by other Labnodes entities: